Vaccine against deadly chytrid fungus primes frog microbiome for future exposure
Vaccine against deadly chytrid fungus primes frog microbiome for future exposure
A human or animal's microbiome—the collection of often beneficial microorganisms, including as bacteria and fungi, that live on or within a host organism—can play an important role in the host's overall immune response, but it is unclear how vaccines against harmful pathogens impact the microbiome. A new study led by researchers at Penn State found that a new vaccine against the deadly chytrid fungus in frogs can shift the composition of the microbiome, making frogs more resilient to future exposure to the fungus.
A human or animal's microbiome—the collection of often beneficial microorganisms, including as bacteria and fungi, that live on or within a host organism—can play an important role in the host's overall immune response, but it is unclear how vaccines against harmful pathogens impact the microbiome. A new study led by researchers at Penn State found that a new vaccine against the deadly chytrid fungus in frogs can shift the composition of the microbiome, making frogs more resilient to future exposure to the fungus.
We use cookies to enhance your browsing experience and provide you with personalized content and relevant advertisements. By continuing to use our website, you consent to the use of cookies as described in our Cookie Policy.